Small Molecule Outsourcing STREAM

  1. Future Of Pharma Packaging: Trends, Tech, And Patient Solutions 9/25/2025

    Explore how traditional and innovative pharmaceutical packaging formats improve patient adherence, support emerging therapies, and shape the future of drug delivery and treatment outcomes.

  2. Accelerating Clinical Development: Modern Tools In Process Chemistry 1/23/2025

    Whether you aim to address bottlenecks or explore advanced techniques, gain a practical and forward-thinking perspective to streamline early-phase development with HTE and model-based approaches.

  3. How To Design An HPAPI Plant And Its Containment Systems

    Dr. Friederike Hermann, head of occupational hygiene and biosafety, shares her expertise on requirements and evaluating the right containment that meets the needs of all process steps and stakeholders.

  4. Cambrex Scientist Spotlight: Daniel Kirschner 1/29/2025

    With a Ph.D. in bioanalytical chemistry from the University of Alaska Fairbanks, Kirschner brings nearly 15 years of experience in pharmaceutical development across biotech and CDMO sectors.

  5. Integrating Early Development With Clinical Supply

    In the era of seamless development, reducing time to the clinic and getting rapid approval is key. An integrated approach can accelerate timelines, avoid communication pitfalls, and improve outcomes.

  6. How Can Nanoparticle Engineering Make The Difference For Alzheimer's? 4/9/2023

    Commercial Insights Officer Jamie Unwin discusses the power of innovative nanoparticle engineering technology and AI-based digital twin.

  7. From Bench To Batch: Strategies For Scaling HPAPI Production

    Highly potent materials bring additional challenges to manufacturing processes. Examine considerations for optimizing HPAPI production methods to reduce risk and deliver therapies to patients with speed.

  8. Improve The Bioavailability Of Poorly Soluble Drugs 3/19/2024

    KinetiSol is a fusion-based, solvent-free process that utilizes frictional and shear energies — in a fraction of the time of other amorphous solid dispersion technologies.

  9. Nanoscale Technology's Potential: A Fireside Chat With Industry Leaders

    Nanoform CEO Edward Haeggstrom and Shawn Davies, head of drug delivery, biopharmaceuticals development, AstraZeneca, discuss the potential of nanoscale medicines and delivery devices.

  10. How To Deal With The Complexity Of Drugs In Clinical Development

    Discover how to advance new compounds with complex chemistry through each stage of development by refining processes to give fit-for-purpose manufacturability and yields.